The Incidence of Recognized Heparin-Induced Thrombocytopenia in a Large, Tertiary Care Teaching Hospital von Smythe, Maureen A., Koerber, John M., Mattson, Joan C.

Volltext

Outcomes of activated prothrombin complex concentrate for direct Xa inhibitor bleeding von Smythe, Maureen A., Koerber, John M., Hoffman, Janet L., Mertz, Sean, Fritsch, Karissa, Chehab, Fatme, Baalbaki, Nour, Krishnan, Anant

Volltext

Hospital Acquired Venous Thromboembolism: A Preventability Assessment von Smythe, Maureen A., Koerber, John M., Roberts, Amanda, Hoffman, Janet L., Batke, Jason

Volltext

Characteristics, Management, and Outcomes of Patients with Atrial Fibrillation Experiencing a Major Bleeding Event While on Rivaroxaban von Burgos, Karen D., Sienko, Sarah E., Hoffman, Janet L., Koerber, John M., Smythe, Maureen A.

Volltext

Dabigatran versus warfarin major bleeding in practice: an observational comparison of patient characteristics, management and outcomes in atrial fibrillation patients von Smythe, Maureen A., Forman, Michael J., Bertran, Elizabeth A., Hoffman, Janet L., Priziola, Jennifer L., Koerber, John M.

Volltext

Implications of Heparin-Induced Thrombocytopenia Overdiagnosis von Smythe, Maureen A., Koerber, John M., Forsyth, Lisa L., Tuchscherer, Rhianna M.

Volltext

Assessing the impact of a heparin-induced thrombocytopenia protocol on patient management, outcomes and cost von Smythe, Maureen A., Koerber, John M., Mehta, Trupti P., Forsyth, Lisa L., Conger, Elizabeth, Corbets, Lindsey R., Mattson, Joan C.

Volltext

The Financial Impact of Heparin-Induced Thrombocytopenia von Smythe, Maureen A, Koerber, John M, Fitzgerald, Maureen, Mattson, Joan C

Volltext

Dalteparin in Critically Ill Patients von Smythe, Maureen A, Koerber, John M

Volltext

Development and implementation of a comprehensive heparin-induced thrombocytopenia recognition and management protocol von Smythe, Maureen A, Mehta, Trupti P, Koerber, John M, Forsyth, Lisa L, Sykes, Elizabeth, Corbets, Lindsey R, Melendy, Susan M, Parikh, Rajul

Volltext

Argatroban Dosage Requirements and Outcomes in Intensive Care versus Non-Intensive Care Patients von Smythe, Maureen A., Koerber, John M., Forsyth, Lisa L., Priziola, Jennifer L., Balasubramaniam, Mamtha, Mattson, Joan C.

Volltext

521: ANTI-INHIBITOR COAGULANT COMPLEX FOR HEMORRHAGE REVERSAL IN PATIENTS TAKING APIXABAN AND RIVAROXABAN von Mertz, Sean, Chehab, Fatme, Koerber, John, Hoffman, Janet, Smythe, Maureen

Volltext

A Comparison of Lepirudin and Argatroban Outcomes von Smythe, Maureen A., Stephens, Jennifer L., Koerber, John M., Mattson, Joan C.

Volltext

93: RIVAROXABAN MAJOR BLEEDING IN PRACTICE von Sienko, Sarah, Burgos, Karen, Hoffman, Janet, Koerber, John, Smythe, Maureen

Volltext

905: CHARACTERIZATION OF WARFARIN MAJOR BLEEDING EVENTS IN REAL-WORLD CLINICAL PRACTICE von Sienko, Sarah, Burgos, Karen, Hoffman, Janet, Koerber, John, Smythe, Maureen

Volltext

Correlation between activated clotting time and activated partial thromboplastin times von Smythe, MA, Koerber, JM, Nowak, SN, Mattson, JC, Begle, RL, Westley, SJ, Balasubramaniam, M

Volltext

The Heparin Anti-Xa Therapeutic Range: Are We There Yet? von Smythe, Maureen A., Mattson, Joan C., Koerber, John M.

Volltext

Use of the activated partial thromboplastin time for heparin monitoring von SMYTHE, Maureen A, KOERBER, John M, WESTLEY, Susan J, NOWAK, Sandra N, BEGLE, Robert L, BALASUBRAMANIAM, Mamtha, MATTSON, Joan C

Volltext

Effect of Lepirudin on the International Normalized Ratio von Stephens, Jennifer L, Koerber, John M, Mattson, Joan C, Smythe, Maureen A

Volltext

Comparing Methods of Establishing the aPTT Therapeutic Range of Heparin von Liepman, Claire I, Koerber, John M, Mattson, Joan C, Westley, Susan J, Smythe, Maureen A

Volltext